Evidence Hub

Contrast Agents for Enhanced Bioimaging: A Comprehensive Review

Taube PS, Fernandes D, Vasconcelos AA, Braga HC, Lima AKO, Costa JAS, Andriani KF, Santos EDCM et al.

Chembiochem : a European journal of chemical biology, 2026

Abstract

Nanotechnology has significantly boosted analytical methods capable of visualizing and characterizing materials at the nanoscale, enabling disease monitoring with high precision. These advances have become particularly relevant in biomedical research, where the demand for enhanced diagnostic tools continues to grow. In this context, contrast agents (CAs) have emerged as essential components in modern imaging techniques, driving efforts toward the development of safer, more efficient, and selective diagnostic materials. The growth in the development of CAs reflects the expansion of applications in imaging modalities. Treatment techniques have benefited from nanotechnology innovations in recent decades, while advancements in imaging modalities demonstrate the demand for next-generation CAs with enhanced resolution and sensitivity. Nanomaterials play a central role in this progress, offering high surface area, adjustable porosity, structural stability, and easy functionalization, for drug delivery and disease monitoring. Hybrid nanoparticles, including core-shell systems, clustered architectures, and nanocomposites integrating metallic or magnetic materials with mesoporous silica, zeolites, or metal-organic frameworks (MOFs), allow control of magnetic relaxivity, X-ray attenuation, optical response, and biological interactions. Molecular scale and nanosized materials contribute to improved contrast, targeted delivery, and enhanced biocompatibility in bioimaging. Together, these…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free